Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement 
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines 
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change 
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores 
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence 
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio 
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown 
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium 
The disease known as monkeypox has surfaced recently due to one reported case found in the United Kingdom. This would be the second time in two years that cases of this disease have been reported in the country again.
The Independent reports that the patient contracted the disease after traveling to Nigeria. They were immediately transferred to the infectious disease center in London. Public Health England stated that they are also working to contact the people who were on the same flight as the patient as well as people whom the patient came into close contact with. They are prepared to take precautionary measures and monitor them in the possibility that they also contract the disease.
The first case of monkeypox in the United Kingdom was in September of 2018, where three people were infected with the virus. Two out of the three people had also come from Africa while the third was a healthcare worker who attended one of the first two cases.
However, the PHE further stated that the monkeypox virus is not very contagious and thus does not spread easily between people. It usually poses a low risk to the general public. Patients who have been infected by this disease normally recover after several weeks. However, there have been some cases where it was fatal.
PHE consultant microbiologist Dr. Meera Chand stated, “PHE and NHS have well established and robust infection control procedures for dealing with cases of imported infectious disease and these will strictly be followed to minimize the risk of transmission.”
Monkeypox is a disease that originates from central and western African countries. While it is not really contagious, it can still be spread by touching items that the infected person has used. The virus can also be transmitted by touching the scabs or spots or being in close proximity with the infected person if they cough or sneeze.
The symptoms of monkeypox include fever, swollen lymph nodes, chills, fatigue, muscle pains, back pains, and chills. As the disease progresses, rashes will begin to form and it usually starts with parts of the face before it spreads to other parts of the body. The rash will eventually change into spots or scabs that eventually fall off.
Treatment for monkeypox takes place in specialist hospitals.
